Hive Legal assisted Nexvet,  a pioneering  Australian veterinary biologic drug developer, with its recent global expansion strategy. This included a private placement to US institutional shareholders,  its redomicile to Ireland and subsequent  IPO on the NASDAQ.

We worked with Nexvet to facilitate these complicated  transactions by providing  greater access to  skilled experienced lawyers throughout the process which is critical for identifying and resolving issues quickly.

“These transactions were designed to advantageously position the company as it undergoes a global expansion. They were large projects which required rapid analysis and execution of several jurisdictional challenges, and Hive’s expertise was invaluable in navigating these waters.”  Geraldine Farrell, Vice-President Operations and General Counsel for Nexvet